...Good afternoon, everyone, and I apologize for that delay. We were having a problem with the audio and couldn't quite figure out whose end it was. So I do apologize, and we'll jump right in, and I'll try not to speak faster. So quickly, I'm going to 'll talk about our operational highlights, where we've been and where we're going. First, I want to thank our shareholders for their support and feedback over the last few months. Obviously, the news received a few weeks ago was not something we expected, but we do think it's something manageable, then we'll get through that I'll talk about. Also, our MannKind employees who worked so hard during Q3 to ensure we are executing on all our 3 key priorities: Tyvaso DPI production and scale, progress of our pipeline and driving Afrezza growth in the U.S. As you look at our revenue, we're really, really happy to see that in Q3 2021, we had $22 million in revenue, which was 45% over last year. And we look at Afrezza that grew 34% to $9.8 million over...
